UM

Browse/Search Results:  1-10 of 468 Help

Selected(0)Clear Items/Page:    Sort:
Trigger and response mechanisms for controlled release of corrosion inhibitors from micro/nanocontainers interpreted using endogenous and exogenous stimuli: A review Journal article
Journal of Materials Science and Technology, 2022,Volume: 125,Page: 67-80
Authors:  Chen, Shan;  Huang, Zhongyu;  Yuan, Mingzhe;  Huang, Guang;  Guo, Honglei;  Meng, Guozhe;  Feng, Zhiyuan;  Zhang, Ping
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/05/13
Controlled Release  Corrosion Protection  Mechanism  Smart Micro/nanocontainers  Stimuli-responsive  
Synthesis and pharmacological validation of fluorescent diarylsulfonylurea analogues as NLRP3 inhibitors and imaging probes Journal article
European Journal of Medicinal Chemistry, 2022,Volume: 237
Authors:  Zhao, Jiannan;  Li, Yongling;  Ma, Jing;  Liu, Jingting;  Xiao, Ruoxuan;  Wang, Linlin;  Li, Peng;  He, Yinyan;  Qian, Feng;  Zhang, Ao;  Sun, Zhen Liang;  Ding, Chunyong
Favorite |  | TC[WOS]:1 TC[Scopus]:1 | Submit date:2022/05/13
Fluorescence Imaging  Inflammasome  Inhibitor  Nlrp3  Sulfonylurea  
α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation Journal article
Phytomedicine, 2022,Volume: 101
Authors:  Chen, Jia Yue;  Zhu, Qi;  Cai, Cui Zan;  Luo, Hai Bin;  Lu, Jia Hong
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/05/31
Alpha-synuclein (Α-syn)  Parkinson's Disease  Phosphodiesterase 4 Inhibitor  Protein Kinase a (Pka)  Ubiquitin-proteasome System (Ups)  
3,4′,5-Trimethoxy-trans-stilbene Alleviates Endothelial Dysfunction in Diabetic and Obese Mice via Activation of the AMPK/SIRT1/eNOS Pathway Journal article
Antioxidants, 2022,Volume: 11,Issue: 7,Page: 1286
Authors:  Tan, Yi;  Zhou, Chunxiu;  Xu, Baojun;  Wang, Yitao;  Cheang, Wai San
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/06/29
FGFR2–BRD4 Axis Regulates Transcriptional Networks of Histone 3 Modification and Synergy Between Its Inhibitors and PD-1/PD-L1 in a TNBC Mouse Model Journal article
Frontiers in Immunology, 2022,Volume: 13
Authors:  Lei, Josh Haipeng;  Zhang, Lei;  Wang, Zhenyi;  Peltier, Raoul;  Xie, Yusheng;  Chen, Ganchao;  Lin, Shiqi;  Miao, Kai;  Deng, Chu Xia;  Sun, Hongyan
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/05/31
BRD4  epigenetic  FGFR2  immunotherapy  posttranslational modifications  TNBC  
Acetyltanshinone IIA reduces the synthesis of cell cycle-related proteins by degrading p70S6K and subsequently inhibits drug-resistant lung cancer cell growth Journal article
Pharmacological Research, 2022,Volume: 179
Authors:  Huang, Bin;  Hao, Meng;  Li, Chuwen;  Luo, Kathy Qian
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/05/13
Acetyltanshinone Iia  Afatinib (Pubchem Cid: 10184653)  Aurora Kinase a  Drug-resistant Lung Cancer  Egfr  Erlotinib (Pubchem Cid: 176870)  Ly294002 (Pubchem Cid: 3973)  Mln8237 (Pubchem Cid: 24771867)  Osimertinib (Pubchem Cid: 71496458)  P70s6k  Pf-4708671 (Pubchem Cid: 51371303)  Rapamycin (Pubchem Cid: 5284616)  Tanshinone Iia (Pubchem Cid: 164676)  
USP13: Multiple Functions and Target Inhibition Journal article
Frontiers in Cell and Developmental Biology, 2022,Volume: 10
Authors:  Li, Xiaolong;  Yang, Ge;  Zhang, Wenyao;  Qin, Biying;  Ye, Zifan;  Shi, Huijing;  Zhao, Xinmeng;  Chen, Yihang;  Song, Bowei;  Mei, Ziqing;  Zhao, Qi;  Wang, Feng
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/05/04
Deubiquitination  Disease  Inhibitor  Structure  Ubiquitin-specific Protease 13  
Targeting glucose metabolism to develop anticancer treatments and therapeutic patents Journal article
Expert Opinion on Therapeutic Patents, 2022,Volume: 32,Issue: 4,Page: 441-453
Authors:  Zhou, Yan;  Guo, Yizhen;  Tam, Kin Yip
Favorite |  | TC[WOS]:0 TC[Scopus]:1 | Submit date:2022/05/17
Cancer Glucose Metabolism  Cancer Treatment Patent  Glycolytic Inhibitor  Hexokinase 2 (Hk2)  Lactate Dehydrogenase a (Ldha)  Pyruvate Dehydrogenase Kinase (Pdk)  Warburg Effect  
Emerging pharmacotherapy for inflammatory bowel diseases Journal article
Pharmacological Research, 2022,Volume: 178
Authors:  Luo, Hua;  Cao, Guiqing;  Luo, Chun;  Tan, Dechao;  Vong, Chi Teng;  Xu, Yinyue;  Wang, Sicen;  Lu, Haitao;  Wang, Yitao;  Jing, Wanghui
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/05/04
Emerging Pharmacotherapy  Ibd  Molecular Pathogenesis  Therapeutic Targets  
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy Journal article
Nature Communications, 2022,Volume: 13,Issue: 1
Authors:  Li, Jianjie;  Shu, Xiaodong;  Xu, Jun;  Su, Sek Man;  Chan, Un In;  Mo, Lihua;  Liu, Jianlin;  Zhang, Xin;  Adhav, Ragini;  Chen, Qiang;  Wang, Yuqing;  An, Tingting;  Zhang, Xu;  Lyu, Xueying;  Li, Xiaoling;  Lei, Josh Haipeng;  Miao, Kai;  Sun, Heng;  Xing, Fuqiang;  Zhang, Aiping;  Deng, Chuxia;  Xu, Xiaoling
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/05/13